Zobrazeno 1 - 10
of 51
pro vyhledávání: '"Kensuke Kondo"'
Autor:
Eiji Takeuchi, Hirokazu Ogino, Kensuke Kondo, Yoshio Okano, Seiya Ichihara, Michihiro Kunishige, Naoki Kadota, Hisanori Machida, Nobuo Hatakeyama, Keishi Naruse, Hiroshi Nokihara, Tsutomu Shinohara, Yasuhiko Nishioka
Publikováno v:
Thoracic Cancer, Vol 15, Iss 3, Pp 248-257 (2024)
Abstract Background An increased relative eosinophil count (REC) has potential as a predictive biomarker for a beneficial clinical response and outcome to cancer immunotherapies. Therefore, the present study investigated the impact of an increased po
Externí odkaz:
https://doaj.org/article/8dd6b6ab412644d4845bdcd09c66afdf
Autor:
Eiji Takeuchi, Kensuke Kondo, Yoshio Okano, Seiya Ichihara, Michihiro Kunishige, Naoki Kadota, Hisanori Machida, Nobuo Hatakeyama, Keishi Naruse, Hirokazu Ogino, Hiroshi Nokihara, Tsutomu Shinohara, Yasuhiko Nishioka
Publikováno v:
Thoracic Cancer, Vol 14, Iss 30, Pp 3042-3050 (2023)
Abstract Background The peripheral blood eosinophil count prior to treatment has potential as a predictive biomarker for a beneficial clinical response to cancer immunotherapies. Therefore, the present study investigated the impact of the eosinophil
Externí odkaz:
https://doaj.org/article/83c945d99b1141fba1983672df71bb1f
Autor:
Hiroshi Nokihara, Hirokazu Ogino, Atsushi Mitsuhashi, Kensuke Kondo, Ei Ogawa, Ryohiko Ozaki, Yohei Yabuki, Hiroto Yoneda, Kenji Otsuka, Yasuhiko Nishioka
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-9 (2022)
Abstract Background Osimertinib is a standard first-line treatment for advanced non-small-cell lung cancer (NSCLC) harboring epidermal growth factor receptor (EGFR) mutations. Although malignant pleural effusion (PE) is a common clinical problem in N
Externí odkaz:
https://doaj.org/article/fd70bfd9fd224ee1bb2c84a89f08739b
Autor:
Masahiro Sako, Hiroshi Nokihara, Kensuke Kondo, Atsushi Mitsuhashi, Ryohiko Ozaki, Yohei Yabuki, Akane Abe, Hiroto Yoneda, Hirokazu Ogino, Kenji Otsuka, Hisanori Uehara, Yasuhiko Nishioka
Publikováno v:
Thoracic Cancer, Vol 13, Iss 1, Pp 129-132 (2022)
Abstract Pulmonary pleomorphic carcinoma is often refractory to chemotherapy and follows an aggressive clinical course. Immune checkpoint inhibitors (ICIs) have revolutionized the treatment of advanced lung cancer, and a few cases with pleomorphic ca
Externí odkaz:
https://doaj.org/article/c87d33cc23b04e469beeecb0208f2c24
Publikováno v:
Clinical Case Reports, Vol 7, Iss 11, Pp 2149-2152 (2019)
Abstract Acute myeloid leukemia (AML) with FUS‐ERG has a poor prognosis regardless of allo‐hematopoietic stem cell transplantation (HSCT). Maintenance therapy such as azacitidine after allo‐HSCT for AML with FUS‐ERG may be clinically meaningf
Externí odkaz:
https://doaj.org/article/dffa815c766c40d99f81c3dbec398201
Autor:
Kensuke Kondo, Yohei Yabuki, Hiroshi Nokihara, Atsushi Mitsuhashi, Hiroto Yoneda, Akane Abe, Masahiro Sako, Yasuhiko Nishioka, Kenji Otsuka, Ryohiko Ozaki, Hirokazu Ogino, Hisanori Uehara
Publikováno v:
Thoracic Cancer
Thoracic Cancer, Vol 13, Iss 1, Pp 129-132 (2022)
Thoracic Cancer, Vol 13, Iss 1, Pp 129-132 (2022)
Pulmonary pleomorphic carcinoma is often refractory to chemotherapy and follows an aggressive clinical course. Immune checkpoint inhibitors (ICIs) have revolutionized the treatment of advanced lung cancer, and a few cases with pleomorphic carcinoma h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::70eb22c5bb6c4d30c22ec7252f445ad8
http://europepmc.org/articles/PMC8720630
http://europepmc.org/articles/PMC8720630
Autor:
Eiji Takeuchi, Kensuke Kondo, Yoshio Okano, Michihiro Kunishige, Yoshihiro Kondo, Naoki Kadota, Hisanori Machida, Nobuo Hatakeyama, Keishi Naruse, Hirokazu Ogino, Hiroshi Nokihara, Tsutomu Shinohara, Yasuhiko Nishioka
Publikováno v:
Journal of Cancer Research and Clinical Oncology.
Purpose Immune checkpoint inhibitors (ICI) are a promising treatment, but may cause hyperprogressive disease and early death. The present study investigated early mortality factors in ICI monotherapy for lung cancer. Patients and methods We retrospec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::458286f8d0b6127e7ef441c8db89b0a5
https://doi.org/10.1007/s00432-022-04215-7
https://doi.org/10.1007/s00432-022-04215-7
Autor:
Tomoki Yamatsuji, Ichiro Morita, Kensuke Kondo, Naomasa Ishida, Masahiko Kuinose, Atsuhisa Ishida, Tatsuya Watanabe, Kotone Tsujimoto, Noriyuki Tokunaga, Munenori Takaoka, Hideo Yoshida, Ryutaro Isoda, Takuro Yukawa, Takuya Fukazawa
Publikováno v:
Surgery Today
Purpose Bioelectrical impedance analysis (BIA) has been used recently to measure the body water of patients with acute heart failure. We used BIA in this study to better understand, and possibly identify a predictive marker for, perioperative water b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f2414743366020a54d624bcab2d5a74b
https://doi.org/10.1007/s00595-020-02184-3
https://doi.org/10.1007/s00595-020-02184-3
Publikováno v:
Clinical Case Reports, Vol 7, Iss 11, Pp 2149-2152 (2019)
Clinical Case Reports
Clinical Case Reports
Acute myeloid leukemia (AML) with FUS‐ERG has a poor prognosis regardless of allo‐hematopoietic stem cell transplantation (HSCT). Maintenance therapy such as azacitidine after allo‐HSCT for AML with FUS‐ERG may be clinically meaningful.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::157dc076a41caf085f5a947494a9ec15
https://doaj.org/article/dffa815c766c40d99f81c3dbec398201
https://doaj.org/article/dffa815c766c40d99f81c3dbec398201
Autor:
Noriyuki, Tokunaga, Tatsuya, Watanabe, Kensuke, Kondo, Kotone, Tsujimoto, Hideo, Yoshida, Masahiko, Kuinose
Publikováno v:
Kyobu geka. The Japanese journal of thoracic surgery. 74(2)
A 69-year-old man was treated with oral anticoagulation for the left ventricular (LV) aneurysm. Echocardiography revealed dyskinetic apex with a mobile thrombus. The estimated LV end-diastolic and end-systolic volume index (LVEDVI, LVESVI) was 76 and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f9493ca035ad042921989ba072aea8ff
https://pubmed.ncbi.nlm.nih.gov/33976013
https://pubmed.ncbi.nlm.nih.gov/33976013